NCT07768917Not yet recruiting
Training on Systemic and Organ Spec. PM in PC
Impact of Prescribed Physical Training on Systemic and Organ Specific Prognostic Markers in Prostate Cancer
Source: ClinicalTrials.gov · Last updated 17 Aug 2026
Brief summary (registry, in English)
This research is being done to assess the impact of a supervised and structured strength and conditioning program on cardiac remodeling in participants with prostate cancer undergoing treatment with external beam radiation therapy and at least 6 months of Gonadotropin-releasing hormone (GnRH) therapy.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 30 Jun 2026
- Start date
- 10 Dec 2026
- Primary completion date
- 31 Jan 2027
- Lead sponsor
- Massachusetts General Hospital
- Diseases
- Prostate cancer
- NCT number
- NCT07768917
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 10 Dec 2026 to the primary completion date, 31 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Has a known medical condition that makes the subject unable to participate in exercise testing (e.g. unrevascularized coronary artery disease, moderate/severe osteoarthritis, prior stroke, or other conditions)
- Receiving or planned to receive other cancer therapy not included in Eligibility Criterion 3.1.3 (other than an antiandrogen during the first month of therapy)
Other
- The following populations will not be considered for inclusion on this trial.
Who the study is looking for
- Have histologically or cytologically confirmed adenocarcinoma of the prostate
- Have not received GnRH agonist or antagonist within the last 12 months
- Planned for initiation of a GnRH agonist or antagonist or bilateral orchiectomy with an intended treatment duration of ≥ 6 months
- Planned for initiation of radiation therapy to the prostate.
- ECOG performance status of 0 or 1
- Ability to understand and the willingness to sign a written informed consent document
- Baseline serum total testosterone level \> 230 ng/dL (the accepted threshold for testosterone supplementation)
- Speak English -\>18 years of age
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Massachusetts General Hospital Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.